Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VDPCP regimen in adult acute lymphoblastic leukemia
ChiCTR-ONRC-14004968Phase 2Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Jul 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pegaspargase, vincristine, daunorubicin, cyclophosphamide and prednisone in acute lymphoblastic leukemia (ALL), sponsored by Ruijin Hospital. Primary endpoints: overall survival, complete remission rate and 1 more. Started Jul 2014; status: recruiting.
02
Drugs
pegaspargasevincristinedaunorubicincyclophosphamideprednisone
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on ChiCTR-ONRC-14004968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-14004968.